Response adaptive salvage with KTd and ASCT for functional high‐risk multiple myeloma—The Australasian Leukemia and Lymphoma Group (ALLG) MM17 Trial.

Saved in:
Bibliographic Details
Title: Response adaptive salvage with KTd and ASCT for functional high‐risk multiple myeloma—The Australasian Leukemia and Lymphoma Group (ALLG) MM17 Trial.
Authors: Turner, R.1 (AUTHOR), Quach, H.2,3 (AUTHOR), Horvath, N.4 (AUTHOR), Kerridge, I.5 (AUTHOR), Lee, E.6 (AUTHOR), Morris, E.7 (AUTHOR), Kalff, A.1 (AUTHOR), Khong, T.1 (AUTHOR), Reynolds, J.1,8 (AUTHOR), Spencer, A.1,8 (AUTHOR) andrew.spencer@monash.edu
Source: British Journal of Haematology. Aug2023, Vol. 202 Issue 3, p530-538. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00071048
DOI:10.1111/bjh.18914